|
Market Closed -
Nasdaq
00:00:00 13/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 26.76 USD | +0.53% |
|
+5.48% | -0.07% |
| 08-18 | Barclays Adjusts Price Target on Amphastar Pharmaceuticals to $23 From $20, Maintains Equalweight Rating | MT |
| 08-07 | Amphastar Pharmaceuticals, Inc., Q2 2026 Earnings Call, Aug 06, 2026 |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| AMPH | Delayed | |
CBOE
| AMPH | Real-time | |
|
Boerse Muenchen
| 29A | Real-time | |
|
Tradegate
| 29A | Real-time | |
|
Deutsche Boerse AG
| 29A | Delayed | |
|
Börse Stuttgart
| 29A | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Neutral |
| Resistance | 27.39 | 27.39 | 29.26 |
| Spread/Res. | -2.30% | -2.30% | -8.54% |
| Spread/Supp. | +6.53% | +24.35% | +58.62% |
| Support | 25.12 | 21.52 | 16.87 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- AMPH Stock
- Charts Amphastar Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
